대한불안의학회지 (Anxiety and mood)

  • 제8권1호
  • /
  • Pages.9-15
  • /
  • 2012
  • /
  • 2586-0151(pISSN)
  • /
  • 2586-0046(eISSN)
대한불안의학회 (Korean Academy of Anxiety Disorders)
권호 표지

EuroQol 도구로 측정한 성인 공황장애 환자의 건강관련 삶의 질 수준

Assessment of Health-Related Quality of Life among Patients with Panic Disorder Using EuroQol in Korea

  • 손명하 (인제대학교 의과대학 서울백병원 정신건강의학과학교실) ;
  • 변금령 (인제대학교 의과대학 서울백병원 정신건강의학과학교실) ;
  • 최병휘 (광명정신건강의학과의원) ;
  • 우종민 (인제대학교 의과대학 서울백병원 정신건강의학과학교실)
  • Son, Myoung-Ha (Department of Psychiatry, Seoul Paik Hospital, Inje University College of Medicine) ;
  • Byun, Keum-Ryung (Department of Psychiatry, Seoul Paik Hospital, Inje University College of Medicine) ;
  • Choi, Byung-Hwi (Kwang-Myoung Psychiatric Clinic) ;
  • Woo, Jong-Min (Department of Psychiatry, Seoul Paik Hospital, Inje University College of Medicine)
  • 투고 : 2011.11.11
  • 심사 : 2012.03.30
  • 발행 : 2012.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : The purpose of this study was to assess the health-related quality of life (HRQoL) for patients with panic disorder using EQ-5D and EQ-VAS, and to examine the relationship between health-related quality of life and clinical outcomes following treatment. Methods : 29 patients with panic disorder were recruited from the Seoul Metropolitan area and 20 patients were followed up after two months of outpatient treatment. The Panic Disorder Severity Scale (PDSS) was used to assess the severity of the panic disorder and the changes in symptoms. HRQoL was assessed with EQ-5D and EQ-VAS at baseline and at two months of treatment. Results : All enrolled panic disorder patients showed significantly impairment of HRQoL in view of the subscales of EQ-5D, EQ-VAS index scores. The severity of PDSS was correlated the HRQoL in the panic patients. After treatment, the EQ-5D, EQ-VAS index scores showed significant improvement. Conclusion : Panic disorder patients suffer from lower HRQoL as well as from symptoms of the disorder. They showed clinical improvement and a restored HRQoL with treatment. These outcomes suggest using the EQ-5D, EQ-VAS such as the HRQoL in the assessment of patients with panic disorder is essential.

키워드

참고문헌

  1. Katschnig H, Amering M, Stolk JM, Ballenger JC. Predictors of quality of life in a long-term followup study in panic disorder patients after a clinical drug trial. Psychopharmacol Bull 1996;32:149-155.
  2. Choi YH, Choi YJ, Park KH, Woo JM. Impact of cognitive behavioral therapy on quality of life in patients with panic disorder. J Korean Neuropsychiatr Assoc 2002;41:1120-1129.
  3. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996;334:835-840. https://doi.org/10.1056/NEJM199603283341306
  4. Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001;33:337-343. https://doi.org/10.3109/07853890109002087
  5. EuroQol: A new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208. https://doi.org/10.1016/0168-8510(90)90421-9
  6. Williams A, Szende A. Measuring self-reported population health: An international perspective based on EQ-5D;2004.
  7. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999;60:427-435. https://doi.org/10.4088/JCP.v60n0702
  8. Mogotsi M, Kaminer D, Stein DJ. Quality of life in the anxiety disorders. Harv Rev Psychiatry 2000;8:273-282. https://doi.org/10.1080/hrp.8.6.273
  9. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL. Quality of life in panic disorder. Arch Gen Psychiatry 1989;46:984-992. https://doi.org/10.1001/archpsyc.1989.01810110026004
  10. Kim SJ, Kim YS, Yoo SW. Quality of life in patients with panic disorder. J Korean Neuropsychiatry Assoc 2001;40:407-415.
  11. Lim YJ, Yu BH, Kim JH. Korean panic disorder severity scale: construct validity by confirmatory factor analysis. Depress Anxiety 2007;24:95-102. https://doi.org/10.1002/da.20206
  12. Kim MH, Cho YS, Uhm WS, Kim S, Bae SC. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic disease. Quality of Life Research 2005;14:1401-1406. https://doi.org/10.1007/s11136-004-5681-z
  13. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997;154:1571-1575.
  14. Kim JB. Development of the Korean version of the panic disorder severity scale. Kor J Psychopathol 2001;10:141-150.
  15. Yang JC, Kim MS, Yu BH, Yoon SC, Lee SH, Seo HS, et al. Korean medication algorithm for panic disorder 2008: Initial treatment strategies. Korean J Psychopharmacol 2009;20:32-39.
  16. Candilis PJ, McLean RY, Otto MW, Manfro GG, Worthington JJ 3rd, Penava SJ, et al. Quality of life in patients with panic disorder. J Nerv Ment Dis 1999;187:429-434. https://doi.org/10.1097/00005053-199907000-00006
  17. Rubin HC, Rapaport MH, Levine B, Gladsjo JK, Rabin A, Auerbach M, et al. Quality of well being in panic disorder: the assessment of psychiatric and general disability. J Affect Disord 2000;57:217-221. https://doi.org/10.1016/S0165-0327(99)00030-0
  18. Sherbourne CD, Wells KB, Judd LL. Functioning and well-being of patients with panic disorder. Am J Psychiatry 1996;153:213-218. https://doi.org/10.1176/ajp.153.2.213
  19. Brunenberg D, Joore, Manuela A, Boonen, Annelies, Nelemans, et al. Comparing SF-6D & EQ-5d: Data from 4 patient populations. iHEA 2007 6th world congress: explorations in health economics paper. Available at SSRN: http://ssrn.com/abstract=992656.
  20. Sung SS, Choi CB, Sung YK, Park YW, Lee HS, Uhm WS, et al. Health-related quality of life using EQ-5D in Koreans. J Rheum Dis 2004;113:254-262.
  21. Han MA, Ryu SY, Park J, Kang MG, Park JG, Kim KS. Health-related quality of life assesment by the EuroQol-5D in some rural adults. J Prev Med Public Health 2008;41:173-180. https://doi.org/10.3961/jpmph.2008.41.3.173
  22. Carrera M, Herran A, Ayuso-Mateos JL, Sierra-Biddle D, Ramirez ML, Ayestaran A, et al. Quality of life in early phases of panic disorder: predictive factors. J Affect Disord 2006;94:127-134. https://doi.org/10.1016/j.jad.2006.03.006
  23. Stahl SM, Gergel I, Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2003;64:1322-1327. https://doi.org/10.4088/JCP.v64n1107
  24. Konig HH, Born A, Gunther O, Matschinger H, Heinrich S, Riedel-Heller SG, et al. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. Health Qual Life Outcomes;8:47.
  25. Marciniak M, Lage MJ, Landbloom RP, Dunayevich E, Bowman L. Medical and productivity costs of anxiety disorders: case control study. Depress Anxiety 2004;19:112-120. https://doi.org/10.1002/da.10131
  26. Sohn JH, Cho MJ, Lee JY, Choi JH, Lee HW, Jeon HJ, Hahm BJ, Chang SM. Impact of mental disorders on functional disability: Effect of non-psychotic common mental disorders on work loss days. J Korean Neuropsychiatr Assoc 2008;47:81-87.
  27. WHO. Mental health atlas 2011. Geneva;2011.